Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: Week 96 efficacy and safety from a randomized phase 3b study

Jan Van Lunzen, Andrea Antinori, Calvin J. Cohen, Jose R. Arribas, David A. Wohl, Armin Rieger, Anita Rachlis, Mark Bloch, Sorana Segal-Maurer, Will Garner, Danielle Porter, Matthew Bosse, David Piontkowsky, Susan K. Chuck, Shampa De-Oertel

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: Week 96 efficacy and safety from a randomized phase 3b study'. Together they form a unique fingerprint.

Medicine & Life Sciences